Cattle: Enroflox 100 is indicated for the treatment of bovine
respiratory disease (BRD) associated with Mannheimia haemolytica,
Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef
and non-lactating dairy cattle; and for the control of BRD in beef and
non-lactating dairy cattle at high risk of developing BRD associate with
M. haemolytica, P. multocida, H. somni and M. bovis. Enroflox 100 is
indicated for the treatment of bovine respiratory disease (BRD)
associated with Manheimia haemolytica, Pasteurella multocida and
Histophilus somni in beef and non-lactating dairy cattle. Swine:
Enroflox 100 is indicated for the treatment and control of swine
respiratory disease (SRD) associated with Actinobacillus
pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis,
Streptococcus suis, Bordetella bronchiseptica and Mycoplasma
hyopneumoniae. Enroflox 100 is indicated for the control of
colibacillosis in groups or pens of weaned pigs where coliacillosis
associated with Escherichia coli has been diagnosed.

• (Loading SDS PDF)  SDS Sheet